Everolimus for Compassionate Use in Multiple Basal Cell Carcinomas

• প্রধান লেখক: Laura Eibenschutz (লেখক), Delia Colombo (লেখক), Caterina Catricalà (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Hindawi Limited, 2013-01-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Everolimus is an inhibitor of the mammalian target of rapamycin (mTOR) and has been shown to have antineoplastic activity in addition to its use as an immunosuppressive agent for the prevention of organ transplant rejection. We report the use of everolimus for the compassionate treatment of four eld...